Neurodermatitis Diagnosis and Treatment

Diagnosis and Differential Diagnosis

Psoriasis can be distinguished from neurodermatitis by the presence of silvery scale, extensor surfaces, nail changes, and less pruritic symptoms, as noted by the British Medical Journal 1, 2

The American Academy of Dermatology recommends applying high-potency topical corticosteroids, such as clobetasol propionate 0.05% or betamethasone dipropionate 0.05%, twice daily to lichenified plaques for 2-4 weeks to break the itch-scratch cycle, with an expected response of 58-92% efficacy in clearing or near-clearing within 2-4 weeks 3, 4
For body/extremity plaques, the use of class 1-2 (ultra-high to high potency) corticosteroids under occlusion is recommended if needed to penetrate thickened skin, while for facial/genital involvement, low-potency corticosteroids (class 5-7) or topical calcineurin inhibitors (tacrolimus 0.1%) should be used to avoid skin atrophy 3, 4

The maintenance phase involves transitioning to weekend-only application of mid-potency corticosteroids while using emollients daily to prevent relapse without causing steroid-induced atrophy, with a gradual tapering of frequency over 2-4 weeks 3, 4

For plaques unresponsive to maximal topical therapy, intralesional triamcinolone acetonide 10-20 mg/mL injected directly into lichenified areas every 3-4 weeks can be considered 4

The use of moderate-potency corticosteroids should be limited to a maximum of 100g per month, with dermatological supervision required for class 1-2 preparations, and annual periods using alternative non-corticosteroid treatments should be planned 3, 4
Common pitfalls to avoid include abrupt corticosteroid withdrawal, inadequate potency for lichenified plaques, and ignoring the itch-scratch cycle, with medications such as NSAIDs, beta-blockers, and lithium potentially worsening pruritus 3, 4, 5